Navigation Links
Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
Date:7/28/2008

ual results or developments anticipated by Vanda will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Therefore, no assurance can be given that the outcomes stated in such forward-looking statements and estimates will be achieved.

All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this release is provided only as of the date of this release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
2. Vanda Pharmaceuticals Announces that it No Longer Intends to Offer Convertible Senior Notes
3. Vanda Pharmaceuticals VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties
4. Vanda Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 8, 2007
5. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
6. Vanda Pharmaceuticals to Present at Natixis Bleichroeders Hidden Gems Conference
7. Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP
8. New Natural Product from Zurich Pharmaceuticals Downs Appetite
9. AUDIO from Medialink and Duramed Pharmaceuticals: Not Your Mothers Menopause
10. Genesis Pharmaceuticals Announces New Board Member and Forms Committees
11. Sound Pharmaceuticals Receives Additional DoD Funding for Its Hearing Regeneration Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...E, Fla. -- A Florida State University College of M...covered an important new layer of regulation in th...er understanding of the way cancer begins. , Wan...t the College of Medicine, said the findings will ... could lead to the design of new drugs that kill c...
(Date:11/21/2008)... Nov. 21 The Providence ...nced that Craig A. Norris, the Company,s,Chief Op...,s Board of,Directors. Mr. Norris, appointment f...on of Steven I. Geringer and returns the board to ...mmittee of the Board. , Mr. Norris, age 41,...
(Date:11/21/2008)...one day lead to a novel technique to combat cancer...althDay News) -- Belgian researchers have discover...of sugar for food, and this might lead to new trea...urvive and proliferate, all cells in the body need...[glucose], a process that requires oxygen. Compare...
(Date:11/21/2008)...ders Intend To Vigorously Protect Investment And R...v. 21 Dr. Stephen Joffe...dment to their Schedule 13D with the U.S. Securiti...filed a 13D disclosing ownership of 11.4% of LCA-V...asikPlus fixed-site laser vision correction center...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7
...h a pound of cure.' -Henry de Bracton – A disea...cause the deepest anguish is preventable. It is no...entable. Sunday, 4 February 2007, is World Cancer ...ying the theme - “Today’s Children, Tomorrow’s Wor...
... loss of muscle tone in the body, which occurs dur...r or anger. Cataplexy is one of the symptoms of// ... asleep. In narcolepsy there are compulsive sleep...tible urge to sleep even in the most unlikely circ...
...nt sports in the world, has continued to grow in p...hildren participating in organized and// unorganiz... children at risk for injury. A study conducted by...d Policy (CIRP) at Columbus Children’s Hospital is...
...new weapon is being investigated.// Scientists ha...nt -oligo fructose, on obese human subjects. The...ural fiber seen in baby foods, cereals and yogurt ... on genetically obese lab rats. Reportedly, oligo...
Other Medicine News:Health News:'Cancer Prevention' - In Your Hands 2Health News:'Cancer Prevention' - In Your Hands 3Health News:Cataplexy During Status Cataplecticus Resembles REM Sleep 2Health News:Study Reveals 1.6 Million Pediatric Soccer Injuries 2
(Date:11/20/2008)...wswire/ -- The Scandinavian-based drug,developmen... studies on its,lead antimicrobial candidate LTX-...udies showed that the novel lytic peptidomimetic h...ntly better towards killing Staphylococcus,aureus...ndard drugs. In,addition to this it has proven ef...
(Date:11/19/2008)...tistical significance , , ISELIN, N.J., Nov...n (Nasdaq: PARS ) today announced results from i...sion (NE) drug delivery technology formulated with...i-center, randomized, double-blinded, placebo-cont...the Company,s 3% Diclofenac Diethanolamine NanoEmu...
(Date:11/19/2008)... Isogen, a contract development and,manufacturing... the first,phase launch of its contract facility ...ddress the process, facility and capacity problems...iched, low-volume clinical and,early-stage commer...anies can invest over $100 million and four years ...
(Date:11/18/2008)...rn more, make a donation or send a Christmas Seals...-USNewswire/ -- Millions will receive Christmas Se...an Lung Association. These decorative holiday stam...ing back to 1907 when the Lung Association led eff...mericans alive today have no vivid memories of how...
Breaking Medicine Technology:Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Isogen Launches Major New Facility to Address Global Biopharma Demand 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Desert Radiologists Sets Safe Practice Standards 17314 1Desert Radiologists Sets Safe Practice Standards 17314 2The Penis Diet 3A A Healthy Solution for Men Challenged by Erectile Dysfunction 17312 1The Penis Diet 3A A Healthy Solution for Men Challenged by Erectile Dysfunction 17312 2Chocolate bar shown to lower cholesterol 2976 1Chocolate bar shown to lower cholesterol 2976 2Health Plan One Closes 246 5 Million Series A Financing 17309 1Health Plan One Closes 246 5 Million Series A Financing 17309 2Health Plan One Closes 246 5 Million Series A Financing 17309 3
...linical Results Demonstrate Potential of ONCONASE ...June 27, 2007 /PRNewswire-FirstCall/ --,Alfacell C...NASE,the company,s lead drug candidate, is active...lls. , The pre-clinical in vitro and in vivo data ... 1: 107-116) through a collaboration,between Alfac...
...ORK--(BUSINESS WIRE)--Jun 27, 2007 - Gentium S.p.A...h clinical and preclinical,data that support the s...f action of Defibrotide in combination with antica...esented both an update,from the Company,s ongoing ...tory or relapsed multiple myeloma with Defibrotide...
Other Medicine Technology:In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 2In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 3Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3
Zeiss offers a full range of filter sets for a variety of applications.
Dust covers for a variety of Zeiss microscopes
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...that offers you much more than you have ever expec...e impressed by the outstanding quality, and functi... work as easy and safe as possible thus increasin... more time for the observation. , Contrasting...
Medicine Products: